Shulman Rogers’ client, Vigene Biosciences, has joined the fight against COVID-19. They now have 2020 GMP manufacturing slots to help manufacture the vaccines for COVID-19 in the following 3 categories:
Adenovirus GMP production expressing certain COVID-19 antigen
